2016 American Transplant Congress Archives - Page 153 of 180

Survey Results Show Strong Support for Allowing Patients Undergoing Desensitization to Keep Their Pre-Desensitization CPRA Allocation Priority.

A. Kucheryavaya,¹ R. Bray,² D. Tyan.³
Survival Advantage in the Elderly with Kidney Transplantation.

G. Spanos,¹ N. Duncan,¹ P. Brookes,¹ D. Goodall,¹ K. Koutroutsos,¹ E. Evangelou,² M. Loucaidou.¹
Survival Advantage with Older Live Donor Compared to Standard Criteria Deceased Donor Kidney Transplantation in Older Recipients.

P. Abrams, M. Cooper, J. Verbesey, R. Ghasemian, M. Grafals, A. Gilbert, J. Moore, J. Fenton, C. Cannon, J. Rapisurra, B. Javaid.
Survival After Second Kidney Transplant: Are We Being Good Stewards?

C. Jay, J. Pugh, G. Halff, G. Abrahamian, F. Cigarroa, N. Stephens, K. Washburn.
Survival Benefit from Kidney Transplantation Using Kidneys from Deceased Donors Over 75 Years.

M. Pérez-Sáez,¹ E. Arcos,² J. Comas,² M. Crespo,¹ J. Lloveras,¹ J. Tort,² J. Pascual,¹ Catalan Renal Registry Committee.²
Survival Benefit of DCD Livers.

X. Luo, A. Massie, D. Segev.
Survival Benefit of High-KDPI Kidneys Among Obese Transplant Candidates.

M. Bowring, A. Massie, X. Luo, D. Segev.
Survival Benefit of Kidney Transplantation in US Adults with Sickle Cell Nephropathy.

T. Purnell, X. Luo, S. Bae, A. Massie, D. Segev.
Survival Benefit of Living Donor ABOi Kidney Transplantation.

A. Massie, B. Lonze, S. Anjum, X. Luo, D. Segev.
Susceptibility Patterns of Pre-Transplant Pseudomonas and Post-Lung Transplant Outcomes in Patients with Cystic Fibrosis.

S. Pouch,¹ E. Lease,² T. Bogdanovich,³ D. Ho,⁴ R. Miller,⁵ M. Estabrook,⁶ T. Babu,⁷ C. Kotton,⁷ C. Shaver,⁸ L. Thomas,⁸ S. Aslam,⁹ T. McCarty,¹⁰ J. Garcia-Diaz,¹¹ K. Doucette,¹² S. Kirkby,¹³ D. van Duin.¹⁴